Centogene Statistics
Total Valuation
Centogene has a market cap or net worth of 4.69 million. The enterprise value is 72.38 million.
| Market Cap | 4.69M |
| Enterprise Value | 72.38M |
Important Dates
The last earnings date was Friday, September 6, 2024.
| Earnings Date | Sep 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Centogene has 29.00 million shares outstanding. The number of shares has increased by 5.04% in one year.
| Shares Outstanding | 29.00M |
| Shares Change (YoY) | +5.04% |
| Shares Change (QoQ) | +2.68% |
| Owned by Insiders (%) | 3.05% |
| Owned by Institutions (%) | 2.94% |
| Float | 11.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.84 |
| EV / Sales | 1.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.06 |
Financial Position
The company has a current ratio of 1.02
| Current Ratio | 1.02 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.53 |
| Interest Coverage | -4.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.76% |
| Return on Capital (ROIC) | -37.10% |
| Revenue Per Employee | 139,710 |
| Profits Per Employee | -102,278 |
| Employee Count | 384 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 14.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.64% in the last 52 weeks. The beta is -0.71, so Centogene's price volatility has been lower than the market average.
| Beta (5Y) | -0.71 |
| 52-Week Price Change | -84.64% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 49.73 |
| Average Volume (20 Days) | 4,366 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.39 |
Income Statement
In the last 12 months, Centogene had revenue of 53.65 million and -39.27 million in losses. Loss per share was -1.40.
| Revenue | 53.65M |
| Gross Profit | 19.56M |
| Operating Income | -40.22M |
| Pretax Income | -38.96M |
| Net Income | -39.27M |
| EBITDA | -36.36M |
| EBIT | -40.22M |
| Loss Per Share | -1.40 |
Balance Sheet
The company has 21.11 million in cash and 88.80 million in debt, giving a net cash position of -67.69 million or -2.33 per share.
| Cash & Cash Equivalents | 21.11M |
| Total Debt | 88.80M |
| Net Cash | -67.69M |
| Net Cash Per Share | -2.33 |
| Equity (Book Value) | -27.95M |
| Book Value Per Share | -0.96 |
| Working Capital | 721,786 |
Cash Flow
In the last 12 months, operating cash flow was -35.09 million and capital expenditures -44,214, giving a free cash flow of -35.14 million.
| Operating Cash Flow | -35.09M |
| Capital Expenditures | -44,214 |
| Free Cash Flow | -35.14M |
| FCF Per Share | -1.21 |
Margins
Gross margin is 36.46%, with operating and profit margins of -74.97% and -73.21%.
| Gross Margin | 36.46% |
| Operating Margin | -74.97% |
| Pretax Margin | -72.62% |
| Profit Margin | -73.21% |
| EBITDA Margin | -67.77% |
| EBIT Margin | -74.97% |
| FCF Margin | -65.50% |
Dividends & Yields
Centogene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.04% |
| Shareholder Yield | -5.04% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Centogene has an Altman Z-Score of -3.97. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.97 |
| Piotroski F-Score | n/a |